Over the last 7 days, the Biotech industry has dropped 3.0%, driven by Moderna declining 29%. Over the past 12 months, the industry was up 15%. Looking forward, earnings are forecast to grow by 28% annually.
Has the U.S. Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Sun, 04 Aug 2024 | US$1.2t | US$165.8b | -US$32,803,544,510.84 | 25.9x | -36.7x | 7.3x |
Tue, 02 Jul 2024 | US$1.1t | US$164.4b | -US$27,968,148,950.64 | 28.8x | -41.1x | 7x |
Thu, 30 May 2024 | US$1.1t | US$164.6b | -US$26,666,955,066.31 | 26.8x | -41.5x | 6.7x |
Sat, 27 Apr 2024 | US$1.1t | US$164.6b | -US$27,388,073,165.09 | 22.6x | -39.1x | 6.5x |
Mon, 25 Mar 2024 | US$1.2t | US$164.3b | -US$23,931,097,513.35 | 21.4x | -48.6x | 7.1x |
Wed, 21 Feb 2024 | US$1.2t | US$169.2b | -US$20,429,726,157.04 | 15.8x | -56.6x | 6.8x |
Fri, 19 Jan 2024 | US$1.4t | US$204.7b | -US$22,508,448,136.00 | 18.3x | -63.1x | 6.9x |
Sun, 17 Dec 2023 | US$1.4t | US$204.7b | -US$22,119,635,723.00 | 19.2x | -61x | 6.6x |
Tue, 14 Nov 2023 | US$1.2t | US$204.5b | -US$21,994,312,170.00 | 18.6x | -54.7x | 5.9x |
Thu, 12 Oct 2023 | US$1.3t | US$207.4b | -US$13,067,336,949.00 | 17.4x | -97.2x | 6.1x |
Sat, 09 Sep 2023 | US$1.3t | US$207.5b | -US$12,633,744,533.00 | 17.4x | -100.7x | 6.1x |
Mon, 07 Aug 2023 | US$1.3t | US$210.2b | -US$10,135,599,050.00 | 15.6x | -124.3x | 6x |
Wed, 05 Jul 2023 | US$1.1t | US$186.2b | -US$16,059,041,068.00 | 13.4x | -69.8x | 6x |
Fri, 02 Jun 2023 | US$1.1t | US$186.0b | -US$15,979,792,463.00 | 11.3x | -69.9x | 6x |
Sun, 30 Apr 2023 | US$1.2t | US$197.1b | -US$6,664,428,484.00 | 13.7x | -173.7x | 5.9x |
Tue, 28 Mar 2023 | US$1.1t | US$199.4b | -US$3,654,764,713.00 | 13.7x | -309.6x | 5.7x |
Thu, 23 Feb 2023 | US$1.1t | US$203.1b | US$67.8m | 16.3x | 16824.6x | 5.6x |
Sat, 21 Jan 2023 | US$1.2t | US$203.8b | US$1.8b | 14.4x | 655.3x | 5.7x |
Mon, 19 Dec 2022 | US$1.2t | US$203.3b | US$1.6b | 14.4x | 713.2x | 5.7x |
Wed, 16 Nov 2022 | US$1.1t | US$202.3b | US$1.3b | 14.5x | 861.9x | 5.6x |
Fri, 14 Oct 2022 | US$1.1t | US$206.1b | US$5.4b | 15.4x | 196.5x | 5.1x |
Sun, 11 Sep 2022 | US$1.1t | US$206.7b | US$5.8b | 15.6x | 188.1x | 5.3x |
Tue, 09 Aug 2022 | US$1.1t | US$208.3b | US$5.8b | 16.6x | 193.7x | 5.4x |
Thu, 07 Jul 2022 | US$1.1t | US$211.5b | US$10.8b | 17.1x | 99.2x | 5.1x |
Sat, 04 Jun 2022 | US$1.0t | US$212.8b | US$11.3b | 16.4x | 88.7x | 4.7x |
Mon, 02 May 2022 | US$1.0t | US$201.1b | US$7.7b | 16.9x | 132.5x | 5x |
Wed, 30 Mar 2022 | US$1.3t | US$221.7b | US$11.8b | 19.7x | 108.6x | 5.8x |
Fri, 25 Feb 2022 | US$1.2t | US$215.7b | US$6.1b | 20.7x | 198.7x | 5.6x |
Sun, 23 Jan 2022 | US$1.2t | US$212.0b | US$2.5b | 23.1x | 493.9x | 5.8x |
Tue, 21 Dec 2021 | US$1.4t | US$212.0b | US$2.8b | 26.2x | 515.7x | 6.8x |
Thu, 18 Nov 2021 | US$1.4t | US$212.1b | US$3.2b | 27.3x | 452.8x | 6.8x |
Sat, 16 Oct 2021 | US$1.5t | US$196.3b | -US$2,601,802,859.00 | 23.6x | -569.7x | 7.6x |
Mon, 13 Sep 2021 | US$1.6t | US$196.4b | -US$2,267,737,004.56 | 21.4x | -687.2x | 7.9x |
Wed, 11 Aug 2021 | US$1.5t | US$197.0b | -US$1,617,777,785.58 | 22.5x | -955x | 7.8x |
-955x
Which industries have driven the changes within the U.S. Healthcare industry?
US Market | -2.81% | |
Healthcare | -0.23% | |
Biotech | -2.99% | |
Biotech | -2.99% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
ABBV AbbVie | US$189.29 | 2.2% +US$7.3b | 28.1% | PE63.1x | |
ALNY Alnylam Pharmaceuticals | US$272.05 | 15.8% +US$5.2b | 46.6% | PS14.9x | |
EXAS Exact Sciences | US$57.35 | 26.6% +US$2.2b | -32.7% | PS4.1x | |
SGEN Seagen | US$228.74 | 4.5% +US$1.8b | 76.5% | PS18.8x | |
GRPH Graphite Bio | US$22.26 | 539.7% +US$1.1b | 861.6% | PB7.1x |